Uppsala, Sweden, November 11, 2011
Beactica, the leading Swedish fragment-based drug discovery company spun out from Uppsala University announces that it is amongst 25 companies nominated as "Technology Rising Stars” by management consultants Deloitte.
"We are delighted to be one of the 25 fastest growing new technology companies in Sweden” says Per Källblad, CEO of Beactica. "This nomination illustrates the world-leading calibre of our scientific team and the quality of the drug discovery technology platform we have created”.
Deloitte’s annual national Rising Star award identifies new fast-growth technology companies and is part of the Technology Fast 50 program. It ranks new technology companies from all sectors on the basis of growth in revenues over the past three years. Beactica has grown more than 500% in this period.
Beactica uses its proprietary technology platform to accelerate and improve drug discovery success for leading pharmaceutical companies, working in important disease areas such as cancer, brain disorders and infectious diseases.
Looking forward Per Källblad said that Beactica will continue to grow in Uppsala, putting further resources into advancing the scope of its platform and deepening its value-generating collaborations with pharmaceutical industry leaders.
For additional information please contact Dr Per Källblad, Beactica CEO, +46 18 56 08 80.
Sign up for the Beactica newsletter to receive our latest news and updates